ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Honokiol inhibits cell migration and invasion by blocking EMT via Snail/Slug axis in endometriosis.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometriosis, a common gynecological disease, leads to dysmenorrhea and infertility. EMT process was closely related to the pathology of endometriosis. More therapies were required to be explored for endometriosis management. The current study was intended to explore the effect of honokiol in endometriosis. Endometriosis endometrial stromal cells (EESCs) were isolated from endometriosis patients for in vitro analysis. Rats were autotransplanted with endometrial tissues for in vivo study. A range of experiments including MTT, wound healing, Transwell, western blot, hematoxylin and eosin staining, immunohistochemical staining, and RIA analysis were carried out to determine the function and mechanism of honokiol in vitro and in vivo. For in vitro analysis, low dose of honokiol treatment induced no cytotoxicity to EESCs. Honokiol treatment suppressed cell migration and invasion of EESCs. Additionally, honokiol inhibited EMT process of EESCs. For in vivo analysis, honokiol treatment significantly improved pathological morphology in endometriosis model rats. Besides, honokiol treatment decreased Ki67 but increased cleaved caspase-3 protein in ectopic endometrium tissues. Moreover, honokiol administration decreased wet weight of ectopic endometrium tissues, E2 and PGE2 levels. Similarly, honokiol also attenuated EMT process in ectopic endometrium tissues. In summary, honokiol inhibits cell migration and invasion by blocking EMT via Snail/Slug axis in endometriosis, which may provide another choice for endometriosis treatment.
Indexed as
Identifiers
41123636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.